Chennai-based Sankara Nethralaya and California-based biotechnology firm International Stem Cell Corporation (ISCO) have formed a collaboration to develop ISCO’s “CytoCor” stem cell-derived corneal tissue. The goal is to use CytoCor to treat corneal blindness and vision impairment.